ReviewFrontiers in cardiovascular medicine2026
The core mechanism of traditional Chinese medicine in improving myocardial fibrosis: restoring the dynamic balance of mitochondrial quality control.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial fibrosis (MF), characterized by excessive collagen deposition, represents an inevitable pathological progression toward end-stage heart disease, underscoring the urgent clinical need for effective reversal strategies. In recent years, the mitochondrial quality control (MQC) system has emerged as a central regulatory hub for maintaining cardiac homeostasis, offering novel insights into the prevention and treatment of MF. This review bridges classical Traditional Chinese Medicine (TCM) therapeutic concepts with modern MQC mechanisms, primarily aiming to evaluate the intervention targets and efficacy of TCM monomers and formulas by detecting alterations in mitochondrial-associated protein expression, gene transcription levels, and organelle ultrastructure. By systematically reviewing experimental evidence of TCM-mediated MQC modulation, this paper highlights the multi-target and systematic advantages of TCM in combating MF, thereby injecting new momentum into the development of contemporary anti-MF therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.